Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Disclosures
• None
2
Objectives
• Identify the most common causes of sudden death in athletesDiscuss incidence and etiologies of sudden death in both younger and middle-aged athletes
• Describe the concept of the “Athlete’s
• Review current pre-participation screening strategies and controversy
Sudden Cardiac Death
Catastrophic Deathprompts a controversial debate
on appropriate pre-participation screening and emergency preparedness
Case presentation
• 18 yo female college athlete referred for cardiac murmur on pre-participation screening.
• 2/6 systolic murmur at LUSB
• ECG: SR, IRBBB, and right axis deviation.
ECG
Case presentation
Case presentation
Sudden Cardiac Arrest
VF is the most frequent initial rhythm in sudden cardiac arrestVF is a useless quivering of the heart that results in no blood flowDefibrillation is the only effective treatment for VF
Heart Attack
1. Vessel lining splits2. Fat deposits
collecting3. Artery narrows
SUDDEN DEATH IN ATHLETES AGE GREATER THAN THIRTY
• Coronary artery disease-97%
• Hypertrophic cardiomyopathy
• Congenital coronary anomalies
• Primary ventricular rhythm disturbances
The Honolulu Advertiser, Sunday, March 12, 2006
CARDIAC EVALUATIONAGE GREATER THAN THIRTY
Considerations
• Assess risk profile
• Exercise stress test for symptoms or abnormal ECG
• Coronary calcium scoring
• Risk factor modification or treatment
• Other testing (ECHO, etc.) based on clinical indications
SCD in the Athlete < 30 yearsPopulation at Risk
• 7 million high school athletes in the United States
• 500,000 college athletes
• 5,000 professional athletes
• Rate has previously been estimated to be 1/200,000 athletes per year
Sudden Cardiac Death
• Sudden cardiac arrest (SCA) in athletes occurs most predominantly between 15-25 years of age
• 60-80% of athletes have no symptoms prior to their SCA
• 90% of SCA occurs during training or competition
PrevalenceYoung Athletes
• Exact numbers unknown – no national
database
• 5X more common in males than females
• Estimated that up to 300 high school
athletes die at an organized sporting
event each year from SCA
Incidence of SCD in NCAA Athletes
• 2004-2008 2 million athlete participation-years
• SCD incidence- 1:43,770
• 2x more common in males (33,134) vs. females (76,646)
• Black > white: 1:17,696 vs 1:58,653
• Highest in Division 1 black male basketball
1:3, 126 vs white 1:12,810.
• Basketball >swimming >lacrosse >football >CC
Asif IM et al Circulation 2011,123:1594-1600
Detection of causes of Sudden Death in Athletes
• Hypertrophic cardiomyopathy (up to 10% have normal ECG)
• Commotio cordis
• Coronary artery abnormalities (Echo)
• LVH of indeterminate causation
• Myocarditis
• Ruptured AA (Marfan syndrome)
• Arrhythmogenic RV cardiomyopathy
• Tunneled (bridged) coronary artery
• Aortic valve stenosis
• Artherosclerotic CAD
• Dilated cardiomyopathy
• Myxomatous mitral valve BJ Maron, et al. JACC 2005;45:1318-21
Distribution of cardiovascular causes of sudden death in 1435 young
competitive athletes.
Maron B J et al. Circulation. 2007;115:1643-1655
Copyright © American Heart Association, Inc. All rights reserved.
Hypertrophic Cardiomyopathy
• Most common cause of SCD in youth
• Familial disorder of increased wall thickness with normal LV size (family history)
• Most have premonitory symptoms
• Most (75%) non-obstructive “no murmur”
• ECG is normal in up to 10%
• Echo for diagnosis vs. “Athlete’s heart”
• Recommendations: no competitive sports
ECG
Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy
Coronary Anatomy
Normal Abnormal
Anomalous RCA
Causes of Sudden CardiacDeath in Young Athletes
Less common
• Coronary artery anomalies• Myocarditis• Wolf-Parkinson-White Syndrome• Long QT Syndrome• Dilated cardiomyopathy• Marfan’s Syndrome• Drugs • Other (sickle cell trait, wt. loss/fluid-
electrolyte imbalances – bulimia)
16 yo athlete with tachycardia and near syncope
Athlete’s Heart
• Structural changes related to intensity
of training
• Physiologic, not pathologic
• Not related to sudden cardiac death
• No long term associated risk
• Regresses with stopping training
Athlete’s Heart
• Structural changes related to intensity of training
• Physiologic, not pathologic
• Not related to sudden cardiac death
• No long term associated risk
• Regresses with stopping training
BJ Maron, et al. JACC 2005;45:1322-6
Gray Areas of Overlap BetweenAthlete’s Heart and Cardiomyopathy
Pre-participation Screening Controversy
• Sudden death in a young athlete is a rare but tragic event
• Most die from previously unsuspected heart disease…
• That more comprehensive screening would likely have identified (ECG and Echocardiogram)
• So why not screen everyone?
Pre-participation challenge:Can we prevent SCD?
• How do you do it? Logistics
• Can it be accomplished? Qualified
personnel
• Is it truly effective?
false positives/negatives
• Cost concerns
• Prospective Data
AHA Consensus Panel Recommendations for
Preparticipation Athletic ScreeningFamily History
– Premature sudden cardiac death– Heart disease in surviving relatives < 50 years old
Personal History– Heart murmur– Systemic HTN– Fatigue– Syncope/near-syncope– Excessive/unexplained exertional dyspnea– Exertional chest pain
Physical Examination– Heart murmur (supine/standing*)– Femoral arterial pulses (to exclude coarctation of aorta)– Stigmata of Marfan syndrome– Brachial blood pressure measurement (sitting)
BJ Maron, et al. JACC 2005;45:1322-6 BJ Maron et al. Circ 2007;115:1643-1655
ECG Screening: Reframing the Debate
• Insufficient evidence for any strategy to show accurate identification of athletes at risk and/or prevention of SCD.
• It is reasonable to screen with ECG and it is reasonable not to.
• Potential benefits and potential harms
• Education of physicians and communities is key
35Drezner JA. Br J Sports Med Jan 2013 47:1;4-5
A.Magalski et al. J Am Coll Cardiol 2008;51:2250-5
Relation of Abnormal and Normal ECG Pattern to Race in 1,959 Professional Football
Players
*p<0.0001, †p=0.0005 for comparisons by race.
1.8
11.2
87
5.8
24.2
70
0
10
20
30
40
50
60
70
80
90
100
Distinctly abnormal Mildly abnormal Normal
% A
thle
tes
White
Black
*
†
Distinct ECG Abnormalities in 964 Collegiate Athletes
14.7
18.1
5.5
8.3
0
2
4
6
8
10
12
14
16
18
20
Perc
en
tag
e (
%)
P<0.001 P<0.001
Male Female Black White
Magalski et al. Am J Med (2011) 124:511-518
ECG in collegiate athleteNormal or Abnormal?
18 yo asymptomatic collegiate basketball player
ECG Screening Interpretation Standards
• “Seattle criteria” with MAHI modifications:
Normal
PR interval (>0.2)
R or S voltage (>25 mm)
Sinus Bradycardia (<60/minute)
ST elevation (> 2 mm), > 2 leads
Incomplete RBBB, RSR’ (<0.12 sec), V1V2
Sinus arrhythmia
PR interval (< 0.12 sec)
Q waves (2-3 mm) depth, > 2 leads
T wave flat, min inverted or tall (> 15 mm), > 2 leads40
ECG Screening Interpretation Standards
“Seattle criteria” with MAHI modifications:
Normal
Abnormal R wave progression
Ectopic atrial rhythm
Wenchebach 2nd degree AV block
PVC (< 2)
PAC (s)
Isorhythmic dissociation
Low voltage
41
Distinctly Abnormal Electrocardiograms1
Pellicia
Criteria2
Uberoi
Criteria3
Abnormal (n) 136 67
Abnormal (%) 10% 4.9%
Sensitivity 91.7 91.7
Specificity 90.8 95.8
Positive predictive value 8.1 16.4
Negative predictive value 99.9 99.9
1. Magalski A et al Am J Med 2012 May 125(5):e132. Pelliccia A et al Circulation. 2000:102(3):278-284
3. Uberoi A et al Circulation 2011:124(6):746-757
Screening with ECG and Echo:Athlete-specific criteria
• 2239 consecutive collegiate varsity athletes at The University of Kansas from 2004-present. (51% female)
• History and Physical, ECG, and Echo in all
• 18 (0.8%) serious findings: 11 WPW
• 4 (0.2%) excluded: 1 Long QT, 1 HCM, 1 dilated aorta, 1 anomalous coronary artery
• 16 other important findings: Ebstein’s, Bicuspid AoV, MVP, ASD, VSD, and dilated aorta - all played
Evaluation Protocol
• Prospective registry of consecutive varsity collegiate athletes
• Extensive questionnaire: personal health history, symptoms, and family history
• Physical exam
• ECG (Seattle criteria)
• Echocardiogram
44Magalski et al. Am J Med (2011) 124:511-518
Cayman Island Athletic Heart Clinic
45
KU athlete
• 20 yo track/cross country athlete with palpitations and tachycardia
• Previously evaluated at Big 10 school for same
• Near syncope with training
• ECG- Normal
• Exam- unremarkable
46
Bizarre finding:Single coronary artery
47
48
Echo Findings in Athletes
Number of
Athletes
Black%
Male%
Any Cardiac
DisorderSerious Minor
DQ (Disqualification)
Baggish et alAnn Int Med2010;152:269-275 510 4% 61%
11 (2.2%)
5 (.98%)
6 (1.2%)
3 (0.6%)
Sheikh et alCirc2014;129:1637-49 3210 33% 94%
40 (1.2%)
15 (.47%)
25 (.78%)
~0.3%
Magalski et alAm J of Med2011;124:511-518 1763 24% 49%
25 (1.6%)
15 (.85%)
14 (.78%)
4(0.23%)
Serious Cardiac Findings in5483 Athletes
49
• Hypertrophic CM- 7 (1,5,1)
• Wolff-Parkinson-White- 15 (0,5,10)
• Long-QT syndrome- 4 (0,3,1)
• Brugada- 1 (0,1,0)
• Anomalous coronary origin from wrong sinus-
1 (0,1,0)
• Severe pulmonic stenosis- 1 (1,0,0)
• Dilated cardiomyopathy- 2 (1,0,1)
Baggish et al. Ann Int Med, Sheikh et al. Circ, Magalski
Other Echo Findings (n=5483)
• Bicuspid aortic valve- 17 (2, 10, 5)
• Mitral valve prolapse- 14 (3, 7, 4)
• VSD- 2 (0,1,1)
• ASD- 5 (0,3,2)
• Dilated aorta- 4 (0,0,4)
• Ebstein’s-1 (0,0,1)
• LVH- 1 (1,0,0)
50
Baggish et al, Sheikh et al, Magalski
Echo Summary
• 1% Serious
• 1% Less Serious
• Disqualification:
0.2 - 0.6%: (1/500 – 1/200)
51
Cost-Effectiveness
• Addition of ECG to pre-participation screening saves 2.06 life-years per 1000 athletes: $42,900- 68,800 per life year saved.
• ECG alone: $37,700 • Cost: $600-900,000 per life saved• Additional general health benefits
Wheeler et al Ann Intern Med 2010; 152: 276-286Schoenbaum et al Pediatrics 2012;130:e380-e389
Reframing the Debate
• Screening is supported!
• Limited outcomes research - more needed
• Intention is to detect potentially lethal cardiovascular disease
• Active management/counseling /informed decision making
• Early detection may not equal disqualification
• Prior eligibility guidelines conservative
53Drezner JA. et al Heart Rhythm 2013;10:454-455
Athlete’s Heart Summary
• Sudden Cardiac Death is uncommon but devastating
• Pursue thorough pre-participation screening-extent of which continues to evolve
• More comprehensive evaluation is feasible, cost-effective, and beneficial